The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma showed an advantage to dupilumab (Dupixent) over ...

No one enjoys having a runny nose—and that includes your dog! Just like humans, dogs can develop runny noses for a variety of reasons. Before you worry, make sure it’s truly a runny nose. A dog’s nose ...

Runny noses and snot are not typically associated with dogs. But, dogs can get runny noses but for very different reasons. Find out why.

The patient - let's call her Melanie - in my consulting room looked absolutely mortified. 'What seems to be the problem,' I ...

Sinus infections, also known as sinusitis, can leave us feeling miserable with symptoms like nasal congestion, facial pain ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

The FDA approved Amgen's and AstraZeneca's drug to treat chronic rhinosinusitis with nasal polyps, an inflammatory condition of the sinuses and nasal passages. The companies said the approval was ...

The FDA on Friday approved a new biologic as add-on maintenance treatment for inadequately controlled chronic rhinosinusitis ...

Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people worldwide, or about 12% of the population. Defined as a long-lasting ...

AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately ...

GSK’s depemokimab shows strong potential for United States Food and Drug Administration approval in asthma and chronic ...